Depressive phenotypes evoked by experimental diabetes are reversed by insulin

Physiology and Behavior

Volumn 105, Issue 3, 2012, Pages 702-708

  Ho, Nancy ^a   Balu, Darrick T ^a   Hilario, Monica R F ^a   Blendy, Julie A ^a   Lucki, Irwin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

BDNF; Behavior; Corticosterone; Depression; Diabetes; ICSS; Insulin; Insulin glargine; Neurogenesis; Streptozotocin; Tail suspension

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; INSULIN; INSULIN GLARGINE; LINBIT; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR CHANGE; C57BL 6 MOUSE; CELL PROLIFERATION; COMORBIDITY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; HIPPOCAMPUS; HYPERGLYCEMIA; IMMOBILIZATION; MALE; MOOD DISORDER; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; STREPTOZOCIN DIABETES;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD GLUCOSE; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; BROMODEOXYURIDINE; CELL PROLIFERATION; CORTICOSTERONE; DEPRESSION; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; HINDLIMB SUSPENSION; HIPPOCAMPUS; HYPOGLYCEMIC AGENTS; IMMOBILITY RESPONSE, TONIC; INSULIN; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; PHENOTYPE; SELF ADMINISTRATION;

EID: 80155214086     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.09.003     Document Type: Article

References (37)

1. Kahn L.S., McIntyre R.S., Rafalson L., Berdine D.E., Fox C.H. Fasting blood glucose and depressive mood among patients with mental illness in a medicaid managed care program. Depress Res Treat 2011, 2011:862708.
2. Egede L.E., Zheng D., Simpson K. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care 2002, 25:464-470.
3. Adili F., Larijani B., Haghighatpanah M. Diabetic patients: psychological aspects. Ann N Y Acad Sci 2006, 1084:329-349.
4. Egede L.E. Disease-focused or integrated treatment: diabetes and depression. Med Clin North Am 2006, 90:627-646.
5. Iosifescu D.V. Treating depression in the medically ill. Psychiatr Clin North Am 2007, 30:77-90.
6. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 2008, 51:216-226.
7. Hirano S., Miyata S., Kamei J. Antidepressant-like effect of leptin in streptozotocin-induced diabetic mice. Pharmacol Biochem Behav 2007, 86:27-31.
8. Miyata S., Hirano S., Kamei J. Diabetes attenuates the antidepressant-like effect mediated by the activation of 5-HT1A receptor in the mouse tail suspension test. Neuropsychopharmacology 2004, 29:461-469.
9. Kamei J., Miyata S., Morita K., Saitoh A., Takeda H. Effects of selective serotonin reuptake inhibitors on immobility time in the tail suspension test in streptozotocin-induced diabetic mice. Pharmacol Biochem Behav 2003, 75:247-254.
10. Carr K.D. Streptozotocin-induced diabetes produces a naltrexone-reversible lowering of self-stimulation threshold. Brain Res 1994, 664:211-214.
11. Carlezon W.A., Chartoff E.H. Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nat Protoc 2007, 2:2987-2995.
12. Jackson-Guilford J., Leander J.D., Nisenbaum L.K. The effect of streptozotocin-induced diabetes on cell proliferation in the rat dentate gyrus. Neurosci Lett 2000, 293:91-94.
13. Saravia F., Revsin Y., Lux-Lantos V., Beauquis J., Homo-Delarche F., De Nicola A.F. Oestradiol restores cell proliferation in dentate gyrus and subventricular zone of streptozotocin-diabetic mice. J Neuroendocrinol 2004, 16:704-710.
14. Saravia F., Beauquis J., Revsin Y., Homo-Delarche F., de Kloet E.R., De Nicola A.F. Hippocampal neuropathology of diabetes mellitus is relieved by estrogen treatment. Cell Mol Neurobiol 2006, 26:943-957.
15. Revsin Y., Saravia F., Roig P., Lima A., de Kloet E.R., Homo-Delarche F., et al. Neuronal and astroglial alterations in the hippocampus of a mouse model for type 1 diabetes. Brain Res 2005, 1038:22-31.
16. Stranahan A.M., Arumugam T.V., Cutler R.G., Lee K., Egan J.M., Mattson M.P. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Nat Neurosci 2008, 11:309-317.
17. Beauquis J., Roig P., Homo-Delarche F., De Nicola A., Saravia F. Reduced hippocampal neurogenesis and number of hilar neurones in streptozotocin-induced diabetic mice: reversion by antidepressant treatment. Eur J Neurosci 2006, 23:1539-1546.
18. Revsin Y., Rekers N.V., Louwe M.C., Saravia F.E., De Nicola A.F., de Kloet E.R., et al. Glucocorticoid receptor blockade normalizes hippocampal alterations and cognitive impairment in streptozotocin-induced type 1 diabetes mice. Neuropsychopharmacology 2009, 34:747-758.
19. Cleck J.N., Ecke L.E., Blendy J.A. Endocrine and gene expression changes following forced swim stress exposure during cocaine abstinence in mice. Psychopharmacology (Berl) 2008, 201:15-28.
20. Crowley J.J., Jones M.D., O'Leary O.F., Lucki I. Automated tests for measuring the effects of antidepressants in mice. Pharmacol Biochem Behav 2004, 78:269-274.
21. Franklin K.B., Paxinos G. The mouse brain in stereotaxic coordinates 1997, Academic Press, Inc., London.
22. Balu D.T., Hodes G.E., Hill T.E., Ho N., Rahman Z., Bender C.N., et al. Flow cytometric analysis of BrdU incorporation as a high-throughput method for measuring adult neurogenesis in the mouse. J Pharmacol Toxicol Meth 2009, 59:100-107.
23. Cryan J.F., Mombereau C., Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 2005, 29:571-625.
24. Hodes G.E., Hill-Smith T.E., Lucki I. Fluoxetine treatment induces dose dependent alterations in depression associated behavior and neural plasticity in female mice. Neurosci Lett 2010, 484:12-16.
25. de Paiva V.N., Lima S.N., Fernandes M.M., Soncini R., Andrade C.A., Giusti-Paiva A. Prostaglandins mediate depressive-like behaviour induced by endotoxin in mice. Behav Brain Res 2010, 215:146-151.
26. Anisman H., Matheson K. Stress, depression, and anhedonia: caveats concerning animal models. Neurosci Biobehav Rev 2005, 29:525-546.
27. Snyder J.S., Soumier A., Brewer M., Pickel J., Cameron H.A. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 2011, 476:458-461.
28. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006, 59:1116-1127.
29. Navaratna D., Guo S.Z., Hayakawa K., Wang X., Gerhardinger C., Lo E.H. Decreased cerebrovascular brain-derived neurotrophic factor-mediated neuroprotection in the diabetic brain. Diabetes 2011, 60:1789-1796.
30. Grunblatt E., Koutsilieri E., Hoyer S., Riederer P. Gene expression alterations in brain areas of intracerebroventricular streptozotocin treated rat. J Alzheimers Dis 2006, 9:261-271.
31. Nitta A., Murai R., Suzuki N., Ito H., Nomoto H., Katoh G., et al. Diabetic neuropathies in brain are induced by deficiency of BDNF. Neurotoxicol Teratol 2002, 24:695-701.
32. Guo J., Yu C., Li H., Liu F., Feng R., Wang H., et al. Impaired neural stem/progenitor cell proliferation in streptozotocin-induced and spontaneous diabetic mice. Neurosci Res 2010, 68:329-336.
33. Nakagawa T., Tsuchida A., Itakura Y., Nonomura T., Ono M., Hirota F., et al. Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes 2000, 49:436-444.
34. Ramanathan M., Jaiswal A.K., Bhattacharya S.K. Differential effects of diazepam on anxiety in streptozotocin induced diabetic and non-diabetic rats. Psychopharmacology 1998, 135:361-367.
35. Jung S.W., Han O.K., Kim S.J. Increased expression of beta amyloid precursor gene in the hippocampus of streptozotocin-induced diabetic mice with memory deficit and anxiety induction. J Neural Transm 2010, 117:1411-1418.
36. Mezuk B., Eaton W.W., Albrecht S., Golden S.H. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008, 31:2383-2390.
37. Katon, W. Depression and diabetes: unhealthy bedfellows. Depress Anxiety. 27:323-6.